Global Microbiome Therapeutics Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of Microbiome Therapeutics will have significant change from previous year. According to our latest study, the global Microbiome Therapeutics market size is USD million in 2022 from USD 89 million in 2021, with a change of % between 2021 and 2022. The global Microbiome Therapeutics market size will reach USD 916.3 million in 2028, growing at a CAGR of 39.5% over the analysis period.
The United States Microbiome Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Microbiome Therapeutics market, reaching US$ million by the year 2028. As for the Europe Microbiome Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Microbiome Therapeutics players cover Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, and Interxon, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Microbiome Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Upper GIT
Lower GIT
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
C. difficile Infection (CDI)
Inflammatory Bowel Disease (IBD)
Orphan Drug
Immuno-oncology
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
AOBiome
C3 Jian
Rebiotix
MicroBiome Therapeutics LLC
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Symbiotix Biotherapies
Osel
Metabogen
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Microbiome Therapeutics Market Size 2017-2028
2.1.2 Microbiome Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Microbiome Therapeutics Segment by Type
2.2.1 Upper GIT
2.2.2 Lower GIT
2.3 Microbiome Therapeutics Market Size by Type
2.3.1 Microbiome Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Microbiome Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Microbiome Therapeutics Segment by Application
2.4.1 C. difficile Infection (CDI)
2.4.2 Inflammatory Bowel Disease (IBD)
2.4.3 Orphan Drug
2.4.4 Immuno-oncology
2.4.5 Others
2.5 Microbiome Therapeutics Market Size by Application
2.5.1 Microbiome Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Microbiome Therapeutics Market Size Market Share by Application (2017-2022)
3 Microbiome Therapeutics Market Size by Player
3.1 Microbiome Therapeutics Market Size Market Share by Players
3.1.1 Global Microbiome Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Microbiome Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Microbiome Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Microbiome Therapeutics by Regions
4.1 Microbiome Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Microbiome Therapeutics Market Size Growth (2017-2022)
4.3 APAC Microbiome Therapeutics Market Size Growth (2017-2022)
4.4 Europe Microbiome Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Microbiome Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Microbiome Therapeutics Market Size by Country (2017-2022)
5.2 Americas Microbiome Therapeutics Market Size by Type (2017-2022)
5.3 Americas Microbiome Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Microbiome Therapeutics Market Size by Region (2017-2022)
6.2 APAC Microbiome Therapeutics Market Size by Type (2017-2022)
6.3 APAC Microbiome Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Microbiome Therapeutics by Country (2017-2022)
7.2 Europe Microbiome Therapeutics Market Size by Type (2017-2022)
7.3 Europe Microbiome Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Microbiome Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Microbiome Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Microbiome Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Microbiome Therapeutics Market Forecast
10.1 Global Microbiome Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Microbiome Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Microbiome Therapeutics Forecast
10.1.3 APAC Microbiome Therapeutics Forecast
10.1.4 Europe Microbiome Therapeutics Forecast
10.1.5 Middle East & Africa Microbiome Therapeutics Forecast
10.2 Americas Microbiome Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Microbiome Therapeutics Market Forecast
10.2.2 Canada Microbiome Therapeutics Market Forecast
10.2.3 Mexico Microbiome Therapeutics Market Forecast
10.2.4 Brazil Microbiome Therapeutics Market Forecast
10.3 APAC Microbiome Therapeutics Forecast by Region (2023-2028)
10.3.1 China Microbiome Therapeutics Market Forecast
10.3.2 Japan Microbiome Therapeutics Market Forecast
10.3.3 Korea Microbiome Therapeutics Market Forecast
10.3.4 Southeast Asia Microbiome Therapeutics Market Forecast
10.3.5 India Microbiome Therapeutics Market Forecast
10.3.6 Australia Microbiome Therapeutics Market Forecast
10.4 Europe Microbiome Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Microbiome Therapeutics Market Forecast
10.4.2 France Microbiome Therapeutics Market Forecast
10.4.3 UK Microbiome Therapeutics Market Forecast
10.4.4 Italy Microbiome Therapeutics Market Forecast
10.4.5 Russia Microbiome Therapeutics Market Forecast
10.5 Middle East & Africa Microbiome Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Microbiome Therapeutics Market Forecast
10.5.2 South Africa Microbiome Therapeutics Market Forecast
10.5.3 Israel Microbiome Therapeutics Market Forecast
10.5.4 Turkey Microbiome Therapeutics Market Forecast
10.5.5 GCC Countries Microbiome Therapeutics Market Forecast
10.6 Global Microbiome Therapeutics Forecast by Type (2023-2028)
10.7 Global Microbiome Therapeutics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Seres Therapeutics
11.1.1 Seres Therapeutics Company Information
11.1.2 Seres Therapeutics Microbiome Therapeutics Product Offered
11.1.3 Seres Therapeutics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Seres Therapeutics Main Business Overview
11.1.5 Seres Therapeutics Latest Developments
11.2 Assembly Biosciences
11.2.1 Assembly Biosciences Company Information
11.2.2 Assembly Biosciences Microbiome Therapeutics Product Offered
11.2.3 Assembly Biosciences Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Assembly Biosciences Main Business Overview
11.2.5 Assembly Biosciences Latest Developments
11.3 Synthetic Biologics
11.3.1 Synthetic Biologics Company Information
11.3.2 Synthetic Biologics Microbiome Therapeutics Product Offered
11.3.3 Synthetic Biologics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Synthetic Biologics Main Business Overview
11.3.5 Synthetic Biologics Latest Developments
11.4 Interxon
11.4.1 Interxon Company Information
11.4.2 Interxon Microbiome Therapeutics Product Offered
11.4.3 Interxon Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Interxon Main Business Overview
11.4.5 Interxon Latest Developments
11.5 PureTech
11.5.1 PureTech Company Information
11.5.2 PureTech Microbiome Therapeutics Product Offered
11.5.3 PureTech Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 PureTech Main Business Overview
11.5.5 PureTech Latest Developments
11.6 Synlogic
11.6.1 Synlogic Company Information
11.6.2 Synlogic Microbiome Therapeutics Product Offered
11.6.3 Synlogic Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Synlogic Main Business Overview
11.6.5 Synlogic Latest Developments
11.7 Enterome BioScience
11.7.1 Enterome BioScience Company Information
11.7.2 Enterome BioScience Microbiome Therapeutics Product Offered
11.7.3 Enterome BioScience Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Enterome BioScience Main Business Overview
11.7.5 Enterome BioScience Latest Developments
11.8 4D Pharma
11.8.1 4D Pharma Company Information
11.8.2 4D Pharma Microbiome Therapeutics Product Offered
11.8.3 4D Pharma Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 4D Pharma Main Business Overview
11.8.5 4D Pharma Latest Developments
11.9 Second Genome
11.9.1 Second Genome Company Information
11.9.2 Second Genome Microbiome Therapeutics Product Offered
11.9.3 Second Genome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Second Genome Main Business Overview
11.9.5 Second Genome Latest Developments
11.10 AOBiome
11.10.1 AOBiome Company Information
11.10.2 AOBiome Microbiome Therapeutics Product Offered
11.10.3 AOBiome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 AOBiome Main Business Overview
11.10.5 AOBiome Latest Developments
11. C3 Jian
11.11.1 C3 Jian Company Information
11.11.2 C3 Jian Microbiome Therapeutics Product Offered
11.11.3 C3 Jian Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 C3 Jian Main Business Overview
11.11.5 C3 Jian Latest Developments
11.12 Rebiotix
11.12.1 Rebiotix Company Information
11.12.2 Rebiotix Microbiome Therapeutics Product Offered
11.12.3 Rebiotix Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Rebiotix Main Business Overview
11.12.5 Rebiotix Latest Developments
11.13 MicroBiome Therapeutics LLC
11.13.1 MicroBiome Therapeutics LLC Company Information
11.13.2 MicroBiome Therapeutics LLC Microbiome Therapeutics Product Offered
11.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 MicroBiome Therapeutics LLC Main Business Overview
11.13.5 MicroBiome Therapeutics LLC Latest Developments
11.14 Metabiomics
11.14.1 Metabiomics Company Information
11.14.2 Metabiomics Microbiome Therapeutics Product Offered
11.14.3 Metabiomics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Metabiomics Main Business Overview
11.14.5 Metabiomics Latest Developments
11.15 Ritter Pharmaceuticals
11.15.1 Ritter Pharmaceuticals Company Information
11.15.2 Ritter Pharmaceuticals Microbiome Therapeutics Product Offered
11.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Ritter Pharmaceuticals Main Business Overview
11.15.5 Ritter Pharmaceuticals Latest Developments
11.16 Symberix
11.16.1 Symberix Company Information
11.16.2 Symberix Microbiome Therapeutics Product Offered
11.16.3 Symberix Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Symberix Main Business Overview
11.16.5 Symberix Latest Developments
11.17 OpenBiome
11.17.1 OpenBiome Company Information
11.17.2 OpenBiome Microbiome Therapeutics Product Offered
11.17.3 OpenBiome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 OpenBiome Main Business Overview
11.17.5 OpenBiome Latest Developments
11.18 Azitra
11.18.1 Azitra Company Information
11.18.2 Azitra Microbiome Therapeutics Product Offered
11.18.3 Azitra Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Azitra Main Business Overview
11.18.5 Azitra Latest Developments
11.19 Symbiotix Biotherapies
11.19.1 Symbiotix Biotherapies Company Information
11.19.2 Symbiotix Biotherapies Microbiome Therapeutics Product Offered
11.19.3 Symbiotix Biotherapies Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Symbiotix Biotherapies Main Business Overview
11.19.5 Symbiotix Biotherapies Latest Developments
11.20 Osel
11.20.1 Osel Company Information
11.20.2 Osel Microbiome Therapeutics Product Offered
11.20.3 Osel Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Osel Main Business Overview
11.20.5 Osel Latest Developments
11.21 Metabogen
11.21.1 Metabogen Company Information
11.21.2 Metabogen Microbiome Therapeutics Product Offered
11.21.3 Metabogen Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Metabogen Main Business Overview
11.21.5 Metabogen Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Microbiome Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Upper GIT
Table 3. Major Players of Lower GIT
Table 4. Microbiome Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Microbiome Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Microbiome Therapeutics Market Size Market Share by Type (2017-2022)
Table 7. Microbiome Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Microbiome Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Microbiome Therapeutics Market Size Market Share by Application (2017-2022)
Table 10. Global Microbiome Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Microbiome Therapeutics Revenue Market Share by Player (2020-2022)
Table 12. Microbiome Therapeutics Key Players Head office and Products Offered
Table 13. Microbiome Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Microbiome Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Microbiome Therapeutics Market Size Market Share by Regions (2017-2022)
Table 18. Americas Microbiome Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Microbiome Therapeutics Market Size Market Share by Country (2017-2022)
Table 20. Americas Microbiome Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Microbiome Therapeutics Market Size Market Share by Type (2017-2022)
Table 22. Americas Microbiome Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Microbiome Therapeutics Market Size Market Share by Application (2017-2022)
Table 24. APAC Microbiome Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Microbiome Therapeutics Market Size Market Share by Region (2017-2022)
Table 26. APAC Microbiome Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Microbiome Therapeutics Market Size Market Share by Type (2017-2022)
Table 28. APAC Microbiome Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Microbiome Therapeutics Market Size Market Share by Application (2017-2022)
Table 30. Europe Microbiome Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Microbiome Therapeutics Market Size Market Share by Country (2017-2022)
Table 32. Europe Microbiome Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Microbiome Therapeutics Market Size Market Share by Type (2017-2022)
Table 34. Europe Microbiome Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Microbiome Therapeutics Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Microbiome Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Microbiome Therapeutics Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Microbiome Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Microbiome Therapeutics Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Microbiome Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Microbiome Therapeutics Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Microbiome Therapeutics
Table 43. Key Market Challenges & Risks of Microbiome Therapeutics
Table 44. Key Industry Trends of Microbiome Therapeutics
Table 45. Global Microbiome Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Microbiome Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Microbiome Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Microbiome Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Microbiome Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Microbiome Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 51. Seres Therapeutics Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 52. Seres Therapeutics Microbiome Therapeutics Product Offered
Table 53. Seres Therapeutics Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Seres Therapeutics Main Business
Table 55. Seres Therapeutics Latest Developments
Table 56. Assembly Biosciences Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 57. Assembly Biosciences Microbiome Therapeutics Product Offered
Table 58. Assembly Biosciences Main Business
Table 59. Assembly Biosciences Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Assembly Biosciences Latest Developments
Table 61. Synthetic Biologics Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 62. Synthetic Biologics Microbiome Therapeutics Product Offered
Table 63. Synthetic Biologics Main Business
Table 64. Synthetic Biologics Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Synthetic Biologics Latest Developments
Table 66. Interxon Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 67. Interxon Microbiome Therapeutics Product Offered
Table 68. Interxon Main Business
Table 69. Interxon Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Interxon Latest Developments
Table 71. PureTech Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 72. PureTech Microbiome Therapeutics Product Offered
Table 73. PureTech Main Business
Table 74. PureTech Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. PureTech Latest Developments
Table 76. Synlogic Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 77. Synlogic Microbiome Therapeutics Product Offered
Table 78. Synlogic Main Business
Table 79. Synlogic Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Synlogic Latest Developments
Table 81. Enterome BioScience Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 82. Enterome BioScience Microbiome Therapeutics Product Offered
Table 83. Enterome BioScience Main Business
Table 84. Enterome BioScience Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Enterome BioScience Latest Developments
Table 86. 4D Pharma Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 87. 4D Pharma Microbiome Therapeutics Product Offered
Table 88. 4D Pharma Main Business
Table 89. 4D Pharma Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. 4D Pharma Latest Developments
Table 91. Second Genome Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 92. Second Genome Microbiome Therapeutics Product Offered
Table 93. Second Genome Main Business
Table 94. Second Genome Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Second Genome Latest Developments
Table 96. AOBiome Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 97. AOBiome Microbiome Therapeutics Product Offered
Table 98. AOBiome Main Business
Table 99. AOBiome Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. AOBiome Latest Developments
Table 101. C3 Jian Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 102. C3 Jian Microbiome Therapeutics Product Offered
Table 103. C3 Jian Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. C3 Jian Main Business
Table 105. C3 Jian Latest Developments
Table 106. Rebiotix Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 107. Rebiotix Microbiome Therapeutics Product Offered
Table 108. Rebiotix Main Business
Table 109. Rebiotix Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. Rebiotix Latest Developments
Table 111. MicroBiome Therapeutics LLC Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 112. MicroBiome Therapeutics LLC Microbiome Therapeutics Product Offered
Table 113. MicroBiome Therapeutics LLC Main Business
Table 114. MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. MicroBiome Therapeutics LLC Latest Developments
Table 116. Metabiomics Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 117. Metabiomics Microbiome Therapeutics Product Offered
Table 118. Metabiomics Main Business
Table 119. Metabiomics Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. Metabiomics Latest Developments
Table 121. Ritter Pharmaceuticals Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 122. Ritter Pharmaceuticals Microbiome Therapeutics Product Offered
Table 123. Ritter Pharmaceuticals Main Business
Table 124. Ritter Pharmaceuticals Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. Ritter Pharmaceuticals Latest Developments
Table 126. Symberix Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 127. Symberix Microbiome Therapeutics Product Offered
Table 128. Symberix Main Business
Table 129. Symberix Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 130. Symberix Latest Developments
Table 131. OpenBiome Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 132. OpenBiome Microbiome Therapeutics Product Offered
Table 133. OpenBiome Main Business
Table 134. OpenBiome Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 135. OpenBiome Latest Developments
Table 136. Azitra Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 137. Azitra Microbiome Therapeutics Product Offered
Table 138. Azitra Main Business
Table 139. Azitra Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 140. Azitra Latest Developments
Table 141. Symbiotix Biotherapies Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 142. Symbiotix Biotherapies Microbiome Therapeutics Product Offered
Table 143. Symbiotix Biotherapies Main Business
Table 144. Symbiotix Biotherapies Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 145. Symbiotix Biotherapies Latest Developments
Table 146. Osel Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 147. Osel Microbiome Therapeutics Product Offered
Table 148. Osel Main Business
Table 149. Osel Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 150. Osel Latest Developments
Table 151. Metabogen Details, Company Type, Microbiome Therapeutics Area Served and Its Competitors
Table 152. Metabogen Microbiome Therapeutics Product Offered
Table 153. Metabogen Microbiome Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 154. Metabogen Main Business
Table 155. Metabogen Latest Developments
List of Figures
Figure 1. Microbiome Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Microbiome Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Microbiome Therapeutics Market Size Market Share by Type in 2021
Figure 7. Microbiome Therapeutics in C. difficile Infection (CDI)
Figure 8. Global Microbiome Therapeutics Market: C. difficile Infection (CDI) (2017-2022) & ($ Millions)
Figure 9. Microbiome Therapeutics in Inflammatory Bowel Disease (IBD)
Figure 10. Global Microbiome Therapeutics Market: Inflammatory Bowel Disease (IBD) (2017-2022) & ($ Millions)
Figure 11. Microbiome Therapeutics in Orphan Drug
Figure 12. Global Microbiome Therapeutics Market: Orphan Drug (2017-2022) & ($ Millions)
Figure 13. Microbiome Therapeutics in Immuno-oncology
Figure 14. Global Microbiome Therapeutics Market: Immuno-oncology (2017-2022) & ($ Millions)
Figure 15. Microbiome Therapeutics in Others
Figure 16. Global Microbiome Therapeutics Market: Others (2017-2022) & ($ Millions)
Figure 17. Global Microbiome Therapeutics Market Size Market Share by Application in 2021
Figure 18. Global Microbiome Therapeutics Revenue Market Share by Player in 2021
Figure 19. Global Microbiome Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Microbiome Therapeutics Market Size 2017-2022 ($ Millions)
Figure 21. APAC Microbiome Therapeutics Market Size 2017-2022 ($ Millions)
Figure 22. Europe Microbiome Therapeutics Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Microbiome Therapeutics Market Size 2017-2022 ($ Millions)
Figure 24. Americas Microbiome Therapeutics Value Market Share by Country in 2021
Figure 25. Americas Microbiome Therapeutics Consumption Market Share by Type in 2021
Figure 26. Americas Microbiome Therapeutics Market Size Market Share by Application in 2021
Figure 27. United States Microbiome Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Microbiome Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Microbiome Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Microbiome Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Microbiome Therapeutics Market Size Market Share by Region in 2021
Figure 32. APAC Microbiome Therapeutics Market Size Market Share by Application in 2021
Figure 33. China Microbiome Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Microbiome Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Microbiome Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Microbiome Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Microbiome Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Microbiome Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Microbiome Therapeutics Market Size Market Share by Country in 2021
Figure 40. Europe Microbiome Therapeutics Market Size Market Share by Type in 2021
Figure 41. Europe Microbiome Therapeutics Market Size Market Share by Application in 2021
Figure 42. Germany Microbiome Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Microbiome Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Microbiome Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Microbiome Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Microbiome Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Microbiome Therapeutics Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Microbiome Therapeutics Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Microbiome Therapeutics Market Size Market Share by Application in 2021
Figure 50. Egypt Microbiome Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Microbiome Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Microbiome Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Microbiome Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Microbiome Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Microbiome Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. APAC Microbiome Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. Europe Microbiome Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Microbiome Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. United States Microbiome Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Canada Microbiome Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Microbiome Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Microbiome Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. China Microbiome Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. Japan Microbiome Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. Korea Microbiome Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Microbiome Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. India Microbiome Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Australia Microbiome Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Germany Microbiome Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. France Microbiome Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. UK Microbiome Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. Italy Microbiome Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. Russia Microbiome Therapeutics Market Size 2023-2028 ($ Millions)
Figure 74. Spain Microbiome Therapeutics Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Microbiome Therapeutics Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Microbiome Therapeutics Market Size 2023-2028 ($ Millions)
Figure 77. Israel Microbiome Therapeutics Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Microbiome Therapeutics Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Microbiome Therapeutics Market Size 2023-2028 ($ Millions)
